Skip to main content

Balyasny Asset Management L.P.

Position in COGT — Cogent Biosciences, Inc.

CIK 1218710 Chicago, IL

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,952,424
+$3,981,967 QoQ
Shares Held
954,843
+11.5% QoQ
Ownership
0.550%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#43
of 323 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COGT Over Time

Shares Held

Position Value (USD)

Derivatives in COGT

reported options exposure · as of Jun 30, 2026
CallValue
$3,870,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. COGT ranks #15 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in COGT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,870,000 100,000
2026-06-30 $36,952,424 954,843
2026-03-31 $32,970,457 856,598
2025-12-31 $51,160,095 1,440,318
2025-09-30 $38,348,178 2,670,486
2025-03-31 $652,927 109,003
2024-12-31 $162,279 20,805
2024-09-30 $206,474 19,118
2024-06-30 $374,637 44,441
2023-09-30 $1,224,970 125,638
2023-03-31 $215,519 19,974
2022-09-30 $15,659,166 1,049,542
2022-06-30 $9,933,753 1,101,303